Imaging, Digital, Angiography Symposium 1

Related

• 

  Systemic Adverse Events in Patients With Diabetes Treated With Intravitreal Antivascular Endothelial Growth Factor Injections

  Roomasa Channa, MD

  Annual Meeting Talks

  2023

• 

  Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

  Andrew J. Barkmeier, MD

  Updates from the Field

  2024

• 

  Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy

  Charles C Wykoff, MD, PhD, FASRS

  Updates from the Field

  2017